Actavis promethazine codeine

Name: Actavis promethazine codeine
SKU: 304
Availability: InStock

Price range: $140.00 through $330.00

Qty

Clear

Add to wishlist

SKU: N/A Categories: Buy Codiene in Canada, Over The Counter Pills in Canada

Actavis Promethazine with Codeine: History, Medical Risks, and Public Health Hazards

Promethazine with codeine is a prescription oral solution that combines an antihistamine with an opioid antitussive (cough suppressant). Historically prescribed to manage severe coughs and upper respiratory symptoms, the brand-name formulation produced by Actavis Holdco US became one of the most recognizable pharmaceutical products in popular culture.

However, due to widespread illicit diversion, severe health risks, and public safety concerns, Actavis voluntarily ceased production of the syrup in 2014. Understanding the pharmacology, risks, and current market reality surrounding this combination is critical from a public health perspective.

What Is Promethazine with Codeine?

Promethazine with codeine combines two distinct active pharmacological agents:

Codeine (Opioid Antitussive): A Schedule V controlled substance that acts on the central nervous system (CNS) to suppress the cough reflex in the brain.
Promethazine (Phenothiazine Antihistamine): A first-generation antihistamine that blocks histamine receptors, reducing secretions, sneezing, and watery eyes, while also exerting strong sedative effects.

When combined, these drugs reduce severe coughing fits associated with respiratory illness. However, both compounds act as central nervous system depressants, meaning their simultaneous use significantly amplifies sedation and respiratory slowing.

Key Pharmacological Profile

Feature	Details
Drug Class	Antihistamine / Opioid Antitussive Combination
Primary Indication	Temporary relief of severe cough and cold/allergy symptoms
Controlled Substance Status	Schedule V (US DEA)
Actavis Status	Permanently Discontinued (April 2014)
Primary Route	Oral Liquid / Syrup
Primary Risks	Respiratory depression, addiction, fatal overdose

Discontinuation of Actavis and the Counterfeit Hazard

In April 2014, Actavis voluntarily and permanently discontinued the manufacture and distribution of its promethazine with codeine product. The decision was driven by the widespread illegal diversion of the syrup, its glamorization in music and youth culture (often referred to as “lean” or “purple drank”), and the rising incidence of abuse and overdose.

The Rise of Dangerous Street Counterfeits

Because legitimate Actavis-branded syrup has not been manufactured in over a decade, any product currently marketed or sold under the “Actavis” brand name is guaranteed to be counterfeit.

Illicit counterfeit bottles often replicate the original purple liquid and pharmaceutical labeling. Testing by forensic laboratories frequently reveals that these counterfeit street liquids contain:

Illicit Fentanyl or Nitazenes: Highly potent synthetic opioids capable of causing fatal overdose in microgram quantities.
Unregulated Benzodiazepines: Synthetic sedatives that drastically increase the risk of respiratory arrest.
Industrial Solvents and Dyes: Toxic chemical compounds causing organ damage.

Major Health Risks and Black Box Warnings

Promethazine with codeine carries severe safety warnings due to its potential for life-threatening toxicity.

1. Fatal Respiratory Depression

Both codeine and promethazine slow breathing rate. When taken at unprescribed doses or combined with alcohol, benzodiazepines, or other narcotics, the respiratory center in the brain can shut down completely, leading to hypoxia, permanent brain damage, or death.

2. Pediatric Restrictions

The FDA issued strict Black Box Warnings prohibiting the use of codeine-containing cough syrups in children under 12 years of age. Additionally, it is contraindicated in adolescents under 18 who have underlying respiratory conditions or who have undergone tonsillectomy or adenoidectomy, due to cases of fatal respiratory depression.

3. Dependence, Addiction, and Withdrawal

Regular use of codeine leads to rapid physical tolerance and psychological dependence. Abrupt cessation after prolonged use triggers severe withdrawal symptoms, including nausea, severe anxiety, muscle cramping, and tremors.

Safe Medical Alternatives

For individuals suffering from acute, disruptive coughs, safe and legal treatment options exist under medical supervision:

Over-the-Counter Antitussives: Medications containing dextromethorphan (DM) provide non-opioid cough suppression.
Prescription Non-Opioid Options: Benzonatate (Tessalon Perles) acts directly on stretch receptors in the lungs without depressing the central nervous system.
Consultation with Healthcare Providers: Addressing the root cause of a cough—such as asthma, bronchitis, or bacterial infection—is far safer and more effective than self-medicating with controlled substances.

If you or someone you know is struggling with substance misuse or opioid dependence, confidential support is available 24/7 through the SAMHSA National Helpline at 1-800-662-4357 (in the US) or local public health services.